Oncolytic measles virus induces tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated cytotoxicity by human myeloid and plasmacytoid dendritic cells

Attenuated measles virus (MV) is currently being evaluated in clinical trials as an oncolytic therapeutic agent. Originally used for its lytic activity against tumor cells, it is now admitted that the effectiveness of MV also lies in its ability to initiate antitumor immune responses through the act...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Achard, Carole, Guillerme, Jean-Baptiste, Bruni, Daniela, Boisgerault, Nicolas, Combredet, Chantal, Tangy, Frédéric, Jouvenet, Nolwenn, Grégoire, Marc, Fonteneau, Jean-François
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2016
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5283625/
https://ncbi.nlm.nih.gov/pubmed/28197384
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1261240
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados